Condition
Pneumococcal Carriage
Total Trials
6
Recruiting
3
Active
3
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Recruiting3
Completed3
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07748832RecruitingPrimary
Pneumococcal Carriage Duration
NCT06731374Phase 4Recruiting
Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15
NCT06373328RecruitingPrimary
Post Pandemic Pneumococcal Carriage Among Children and Adults
NCT05175014Phase 4CompletedPrimary
Mass Campaigns With Fractional Dose Pneumococcal Vaccines in Sub-Saharan Africa (fPCV)
NCT01660659Not ApplicableCompletedPrimary
Indoor Air Pollution (IAP) Carriage Study
NCT00894764Completed
The Study of Chest Infections in Infants Living in a Refugee Camp on the Thai-Burmese Border
Showing all 6 trials